Method of assessing activity of recombinant antigen receptors
AssigneeJuno Therapeutics, Inc.
InventorsRupesh Amin, Aye Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeJuno Therapeutics, Inc.
InventorsRupesh Amin, Aye Chen
Estimating the term…
Provided herein are methods for screening for one or more activity of a recombinant receptor, including recombinant receptors containing an extracellular antigen-binding domain and an intracellular signaling domain, such as a chimeric antigen receptor (CAR). The methods include assessing activity of a cell expressing the recombinant receptor based on a detectable expression of a reporter molecule that is responsive to a signal through the intracellular signaling region of the recombinant receptor. In some embodiments, the activity assessed is an antigen-dependent or an antigen-independent activity. In some embodiments, the methods can be used to screen a plurality of reporter cells each containing a nucleic acid molecule encoding a candidate recombinant receptor, e.g. CAR, and assessing such cells or plurality of cells for one or more property or activity. The methods can be high-throughput. Also provided are reporter cells, cell compositions, nucleic acids and kits for use in the methods.
A method for assessing activity of a recombinant receptor, comprising:
Dependencies are inferred from the claim text.